The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

FASTER COVID-19 recovery… but with an EGREGIOUS price tag! [Disgusting]

It was the $64,000 question…

And now, we finally have the answer.

The maker behind a drug authorized to treat severely ill COVID-19 patients has announced its price tag…

And it’s a doozy.

I guess the idea that Big Pharma is looking to CASH IN on a drug amid a pandemic shouldn’t shock me.

But there’s another aspect to this story you may not know about – one that blows the lid off WHY the drugmaker’s attempts to PROFIT off sick people isn’t just GREEDY.

It’s downright UNFAIR!

Here’s how the feds are letting one drug company take advantage of a health crisis… and of YOU.

Public funding for a private cash grab

So far, it’s the first – and only – antiviral drug to successfully come out of COVID-19 clinical trials.

And the FDA has issued an emergency authorization for it to treat hospitalized coronavirus patients.

I’m talking about remdesivir.

Researchers say the benefit is “modest.” But cases have shown that ANY little bit of help could make a difference between breathing on your own… and going on a ventilator.

Specifically, remdesivir appears to SLASH 4 days off of the average hospitalization time…

Although coming home 4 days SOONER doesn’t seem to make a statistically significant difference in COVID-19 survival rates.

And it turns out those 4 days come at a hefty price!

If you’ve got private insurance… and you find yourself hospitalized with COVID-19… its maker, Gilead Sciences, will charge $3,120 for the standard course of treatment.

Now, your own out-of-pocket costs will vary, depending on your insurance. And we don’t yet know how much public insurance like Medicaid will cover, either.

And I think most folks would agree that any day you DON’T have to wake up in a hospital bed is worth $780.

But you can imagine the “sticker shock” that current COVID-19 patients about to receive the drug might be experiencing…

And you might be wondering whether your insurance will CAP those costs, should you need to take remdesivir yourself.

Here’s the kicker…

You’ve ALREADY paid for remdesivir!

After Gilead invented it 10 years ago… the company let it sit until the U.S. government provided least $70 million of taxpayers’ money for it to develop the drug as an antiviral.

Now, that’s just a FRACTION of what Gilead SAYS developing and manufacturing the drug will cost in 2020 – which is supposedly $1 billion.

But according to an independent analysis conducted by The Institute for Clinical and Economic Review, raw materials to make a 10-day course of treatment of remdesivir cost just under a whopping .

That’s right – only .

Yet Gilead’s CEO Daniel O’Day claims that the company has priced the drug “well below its value”… and that its cost is NOTHING compared to how much you’d have to fork over for those 4 extra days in the hospital.

That’s right – they’re already JUSTIFYING a higher price!

WILL it actually go up? No one knows for sure.

But we know that Gilead CAN and WILL charge LESS for remdesivir.

Other “developed” countries outside the U.S. will pay prices that are 25% LOWER… and “developing” countries will have access to a MUCH cheaper generic version.

They think they can get MORE out of you… even though you’ve already invested in the drug with the taxes you’ve paid!

Gilead DIDN’T consult the public that FUNDED remdesivir’s development – it didn’t HAVE to.

YOUR MONEY helped subsidize the drug… yet you had ZERO say in the pricing.

And Gilead retains EXCLUSIVE control over the patent!

You know what that means…

You’re NEVER getting a return on your investment.

In fact, if you need to reap the benefits provided by the drug… you’ll have to PAY UP… yet again.

Listen, I’m grateful and hopeful that this so-called “reject” drug was RESCUED from the shelves where it was being “mothballed”…

And that it shows some promise in SPEEDING UP the recovery of patients who are terribly sick.

But this is a bad deal all around.

So, this is no time to rest on our laurels. We can’t think that if we get sick… we’ll just take a drug that’ll make it all better.

Even if remdesivir had a 100% success rate… which it DOESN’T… there are too many folks who’d NEVER be able to afford it!

Better to NEVER need a drug like this at all!

I know it feels like this year will never end – but just keep doing what you’re doing.

Help your immune system run smoothly… and reduce your exposure to anything that might make your defenses work harder than usual.

 

To not paying through the nose,

Melissa Young

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.